Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Martin Garber, DO, & David Fivenson, MD  |  Issue: October 2020  |  October 19, 2020

Conclusion

We present an unusual case of a 40-year-old who had been taking minocycline for three years to treat acne vulgaris. He developed acute, bilateral, lower extremity mononeuritis multiplex-associated vasculitis meeting the ACR criteria for PAN.19 As with minocycline-
associated systemic lupus and autoimmune hepatitis and other drug-induced auto­immune diseases, a high index of suspicion and prompt removal of the offending agent is key to clinical remission.

Similarities between our case and cases of minocycline-associated primary vasculitic neuropathy found in the literature may assist with this recognition (see Table 3). Almost all cases involved the long-term (two years on average) use of minocycline for acne vulgaris. Skin manifestations, including livedo reticularis and purpuric papules, were present in our patient and common in the cases previously reported, as were symptoms of generalized arthralgias and myalgias.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Table 3: Common Features of Minocycline-Associated Vasculitis

• Several years (average 2) of patient exposure to minocycline before symptoms appear;
• Skin involvement (livedo reticularis and cutaneous nodules);
• Myalgias and arthralgias;
• P-ANCA positivity without ANCA vasculitis features; and
• Rapid clinical improvement after discontinuing minocycline.

Our case and those reviewed underscore the importance of recognizing the association of positive ANA and P-ANCA tests with long-term minocycline use. Long-term immunosuppressive treatment is not necessary for these patients. All patients reported in the literature responded quickly (within four to 12 weeks) to withdrawal of minocycline. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Martin Garber, DO, is a lecturer in the Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor. He is also an instructor in internal medicine in the Division of Rheumatology at the University of Michigan Medical School.

David Fivenson, MD, is the director of Fivenson Dermatology, Ann Arbor, Mich.

References

  1. Elkayam O, Yaron M, Capsi D. Minocycline-induced autoimmune syndromes: An overview. Semin Arthritis Rheum. 1999 Jun;28(6):392–397.
  2. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999 Mar 8;159(5):493–497.
  3. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011 Apr;56(4):958–976.
  4. Garrido-Mesa N, Zarzuelo A, Galvez J. Minocycline: Far beyond an antibiotic. Br J Pharmacol. 2013 May;169(2):337–352.
  5. Matsuura T, Shimizu Y, Fujimoto H, et al. Minocycline-related lupus. Lancet. 1992 Dec 19–26;340 (8834–8835):1553.
  6. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systemic review. Dermatology. 2000;200(3):223–231.
  7. Gwathmey KG, Burns TM, Collins MP, Dyck PJB. Vasculitic neuropathies. Lancet Neurol. 2014 Jan;13(1):67–82.
  8. Lenert P, Icardi M, Dahmoush L. ANA(+) ANCA(+) systemic vasculitis associated with the use of minocycline: Case-based review. Clin Rheumatol. 2013 Jul;32(7):1099–1106.
  9. Kermani TA, Ham EK, Camilleri MJ, Warrington KJ. Polyarteritis nodosa-like vasculitis in association with minocycline use: A single-center case series. Semin Arthritis Rheum. 2012 Oct;42(2):213–221.
  10. Thaisetthawatkul P, Sundell R, Robertson CE, Dyck PJ. Vasculitic neuropathy associated with minocycline use. J Clin Neuromusc Dis. 2011 Jun;12(4):231–234.
  11. Starr MR, Tillema J-M, Ytterberg SR, et al. Minocycline-induced vasculitis presenting as a third nerve palsy. J Neuropthalmol. 2019 Jun;39(2):240–241.
  12. Garg N, Altowaijri GH, Nesbit GM, et al. Minocycline-associated vasculitis of extracranial branches of vertebral arteries presenting as myelopathy. Neurol Neuroinnunol Neuroinflamm. 2014 May 15;1(1):e7.
  13. Ogawa N, Kawai H, Yamakawa I, et al. [Case of minocycline-induced vasculitic neuropathy] (article in Japanese). Rinsho Shinkeigaku. 2010 May;50(5):301–305.
  14. Katada Y, Harada Y, Azuma N, et al. Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Mod Rheumatol. 2006;16(4):256–259.
  15. Klaas JP, Matzke T, Makol A, Fulgham JR. Minocycline-induced polyarteritis nodosa-like vasculitis presenting as a brainstem stroke. J Clin Neurosci. 2015 May;22(5):904–907.
  16. Baratta JM, James P, Dyck B, et al. Vasculitic neuropathy following exposure to minocycline. Neurol Neuroimmunol Neuroinflamm. 2015 Nov 12;3(1):e180.
  17. McMillan HJ, Jansen GH, Koujok K, et al. Mononeuritis multiplex associated with minocycline in an adolescent. Muscle Nerve. 2017 Oct;56(4):E33–E35.
  18. Marzo-Ortega H, Baxter K, Strauss RM, et al. Is minocycline therapy in acne associated with antineutrophile cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol. 2007 May;156(5):1005–1009.
  19. Lightfoot RW Jr., Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990 Aug;33(8):1088–1093.

Authors’ note: Special thanks to John Sherbeck, MD, Department of Pathology, St. Joseph Mercy Hospital, Ann Arbor, Mich.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:minocyclinepolyarteritis nodosavasculitic neuropathy

Related Articles
    A transverse view of the ulnar groove in full elbow extension. The red arrow indicates the advancing edge of the MHTr.

    Recurrent Medial Elbow Pain Following Successful Tommy John Surgery

    August 12, 2020

    A 27-year-old, left-handed man was referred to our ultrasound clinic for left elbow pain. History The patient had been a pitcher on a Minor League Baseball team. Two years before, he developed sudden, severe medial elbow pain while pitching in a game. The pain was associated with some tingling down the left medial forearm. The…

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Ortho Angle

    August 1, 2009

    Where rheumatology and orthopedics meet

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences